⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28910180 | 0.97 | — | — | |
| SCHEMBL28895235 | 0.97 | — | — | |
| SCHEMBL28645287 | 0.72 | — | — | |
| SCHEMBL29236340 | 0.69 | — | — | |
| SCHEMBL1866401 | 0.68 | — | — | |
| SCHEMBL3542283 | 0.68 | — | — | |
| SCHEMBL29133784 | 0.68 | — | — | |
| Bromide SCHEMBL29260637 | 0.67 | — | — | |
| SCHEMBL29049655 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL29260638 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111432873-B | Treatment of type 1 diabetes | 加尔瓦尼生物电子有限公司 | 2024-08-13 | — | — | CN | claimed |
| US-12390424-B2 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-08-19 | — | — | US | disclosed |
| CN-115380030-B | N-heteroarylalkyl-2- (heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists | 武田药品工业株式会社 | 2025-05-16 | — | — | CN | disclosed |
| CN-115443162-B | Drug injection device, system and method | 解决方案医疗公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119907662-A | Fast dissolving soft gel capsule | R·P·谢勒技术有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119816301-A | Enteric coated soft gel capsule | R·P·谢勒技术有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-118843626-A | Heterocyclic compounds as DYRK1A inhibitors | 普罗塞纳生物科学有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-115485273-B | N- (heterocyclyl and heterocyclylalkyl) -3-benzyl pyridin-2-amine derivatives as SSTR4 agonists | 武田药品工业株式会社 | 2024-08-13 | — | — | CN | disclosed |
| CN-111432873-B | Treatment of type 1 diabetes | 加尔瓦尼生物电子有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-118339176-A | Engineered myocardial composition | 博德研究所 | 2024-07-12 | — | — | CN | disclosed |
| CN-111093665-A | Organic compounds | 细胞内治疗公司 | 2020-05-01 | — | — | CN | disclosed |
| CN-106220572-B | Pyridazine derivative compound, application, composition and kit and preparation method | 因西必泰克新有限公司 | 2019-12-13 | — | — | CN | disclosed |
| US-20190029972-A1 | SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-01-31 | — | — | US | disclosed |
| US-10117840-B2 | Sulfur(VI) fluoride compounds and methods for the preparation thereof | THE SCRIPPS RESEARCH INSTITUTE (US) | 2018-11-06 | — | — | US | disclosed |
| US-20170196985-A1 | SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2017-07-13 | — | — | US | disclosed |
| EP-3151817-A1 | SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | The Scripps Research Institute (US) | 2017-04-12 | — | — | EP | disclosed |
| WO-2015188120-A1 | SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 2015-12-10 | — | — | WO | disclosed |
| US-8470812-B2 | Substituted benzo-pyrimido-tetrazolo-diazepine compounds | ARQULE, INC. (US) | 2013-06-25 | — | — | US | disclosed |
| US-20110166127-A1 | Substituted Benzo-Pyrimido-Tetrazolo-Diazepine Compounds | ARQULE, INC. (US) | 2011-07-07 | — | — | US | disclosed |
| WO-2011082269-A2 | SUBSTITUTED BENZO-PYRIMIDO-TETRAZOLO-DIAZEPINE COMPOUNDS | ARQULE, INC. (US) | 2011-07-07 | — | — | WO | disclosed |